Compare HOUR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | NTRB |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 72.6M |
| IPO Year | 2021 | 2019 |
| Metric | HOUR | NTRB |
|---|---|---|
| Price | $1.81 | $6.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.2K | ★ 130.7K |
| Earning Date | 11-11-2026 | 09-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 150.00 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $142,440,236.00 | $2,036,651.00 |
| Revenue This Year | N/A | $4,584.65 |
| Revenue Next Year | N/A | $89.09 |
| P/E Ratio | $36.72 | ★ N/A |
| Revenue Growth | ★ 3.03 | N/A |
| 52 Week Low | $1.67 | $2.80 |
| 52 Week High | $3.18 | $9.19 |
| Indicator | HOUR | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 49.69 |
| Support Level | $1.74 | $6.56 |
| Resistance Level | $2.05 | $9.19 |
| Average True Range (ATR) | 0.11 | 0.94 |
| MACD | -0.00 | -0.29 |
| Stochastic Oscillator | 21.87 | 26.97 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.